{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:27:06Z","timestamp":1791977226108,"version":"4.4.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"vor","delay-in-days":185,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01 HD058880"],"award-info":[{"award-number":["R01 HD058880"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Human Genetics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ajhg.2020.10.001","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T11:40:20Z","timestamp":1603453220000},"page":"911-931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model"],"prefix":"10.1016","volume":"107","author":[{"given":"Faycal","family":"Guedj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley E.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen L.A.","family":"Pennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah","family":"Alsebaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren J.","family":"Massingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umadevi","family":"Tantravahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana W.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajhg.2020.10.001_bib1","doi-asserted-by":"crossref","first-page":"e010002","DOI":"10.1136\/bmjopen-2015-010002","article-title":"Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis","volume":"6","author":"Taylor-Phillips","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajhg.2020.10.001_bib2","first-page":"729","article-title":"Pregnancy outcomes after prenatal diagnosis of aneuploidy","volume":"97","author":"Ralston","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/pd.4134","article-title":"Noninvasive prenatal testing creates an opportunity for antenatal treatment of Down syndrome","volume":"33","author":"Guedj","year":"2013","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.ajhg.2020.10.001_bib4","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/nm.2829","article-title":"From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges","volume":"18","author":"Bianchi","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ajhg.2020.10.001_bib5","first-page":"181","article-title":"Brain growth in Down syndrome subjects 15 to 22\u00a0weeks of gestational age and birth to 60\u00a0months","volume":"9","author":"Schmidt-Sidor","year":"1990","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1750-3639.2007.00113.x","article-title":"Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome","volume":"18","author":"Guidi","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1750-3639.2010.00459.x","article-title":"Widespread proliferation impairment and hypocellularity in the cerebellum of fetuses with down syndrome","volume":"21","author":"Guidi","year":"2011","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib8","first-page":"55","article-title":"Postnatal delay of myelin formation in brains from Down syndrome infants and children","volume":"8","author":"Wisniewski","year":"1989","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijdevneu.2011.11.005","article-title":"Impaired myelination of the human hippocampal formation in Down syndrome","volume":"30","author":"\u00c1brah\u00e1m","year":"2012","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.ajhg.2020.10.001_bib10","first-page":"305","article-title":"Habituation in normal and Down\u2019s syndrome fetuses","volume":"44","author":"Hepper","year":"1992","journal-title":"Q.\u00a0J. Exp. Psychol. B"},{"key":"10.1016\/j.ajhg.2020.10.001_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/GCO.0000000000000056","article-title":"Prenatal treatment of Down syndrome: a reality?","volume":"26","author":"Guedj","year":"2014","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fnbeh.2015.00265","article-title":"Timing of therapies for Down syndrome: the sooner, the better","volume":"9","author":"Stagni","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.ajhg.2020.10.001_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/DDDT.S51476","article-title":"Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations","volume":"9","author":"Gardiner","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ajhg.2020.10.001_bib14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.molmed.2019.10.001","article-title":"Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome","volume":"26","author":"Lee","year":"2020","journal-title":"Trends Mol. Med."},{"issue":"Suppl 3","key":"10.1016\/j.ajhg.2020.10.001_bib15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1289\/ehp.00108s3511","article-title":"Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models","volume":"108","author":"Rice","year":"2000","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ajhg.2020.10.001_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neubiorev.2014.12.001","article-title":"Sensitive and critical periods during neurotypical and aberrant neurodevelopment: a framework for neurodevelopmental disorders","volume":"50","author":"Meredith","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ajhg.2020.10.001_bib17","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/brain\/awt340","article-title":"Prenatal pharmacotherapy rescues brain development in a Down\u2019s syndrome mouse model","volume":"137","author":"Guidi","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.ajhg.2020.10.001_bib18","doi-asserted-by":"crossref","first-page":"e50724","DOI":"10.1371\/journal.pone.0050724","article-title":"Prenatal treatment prevents learning deficit in Down syndrome model","volume":"7","author":"Incerti","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ajhg.2020.10.001_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.nbd.2014.06.001","article-title":"Maternal choline supplementation improves spatial mapping and increases basal forebrain cholinergic neuron number and size in aged Ts65Dn mice","volume":"70","author":"Ash","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ajhg.2020.10.001_bib20","doi-asserted-by":"crossref","first-page":"9425","DOI":"10.1073\/pnas.0903909106","article-title":"Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses","volume":"106","author":"Slonim","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2020.10.001_bib21","doi-asserted-by":"crossref","first-page":"32353","DOI":"10.1038\/srep32353","article-title":"An integrated human\/murine transcriptome and pathway approach to identify prenatal treatments for Down syndrome","volume":"6","author":"Guedj","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ajhg.2020.10.001_bib22","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ajhg.2020.10.001_bib23","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4103\/1673-5374.162686","article-title":"Curcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer\u2019s disease","volume":"10","author":"Venigalla","year":"2015","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ajhg.2020.10.001_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuint.2015.10.011","article-title":"Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer\u2019s disease","volume":"95","author":"Venigalla","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ajhg.2020.10.001_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.biopha.2017.01.162","article-title":"Apigenin attenuates hippocampal oxidative events, inflammation and pathological alterations in rats fed high fat, fructose diet","volume":"89","author":"Kalivarathan","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ajhg.2020.10.001_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1742-2094-5-41","article-title":"Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression","volume":"5","author":"Rezai-Zadeh","year":"2008","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ajhg.2020.10.001_bib27","doi-asserted-by":"crossref","first-page":"dmm031013","DOI":"10.1242\/dmm.031013","article-title":"Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1\/Yey mouse models of Down syndrome","volume":"11","author":"Aziz","year":"2018","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.ajhg.2020.10.001_bib28","doi-asserted-by":"crossref","first-page":"e16220","DOI":"10.7554\/eLife.16220","article-title":"Trisomy 21 consistently activates the interferon response","volume":"5","author":"Sullivan","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.ajhg.2020.10.001_bib29","doi-asserted-by":"crossref","first-page":"9949","DOI":"10.3390\/molecules18089949","article-title":"Neuroprotective, anti-amyloidogenic and neurotrophic effects of apigenin in an Alzheimer\u2019s disease mouse model","volume":"18","author":"Zhao","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ajhg.2020.10.001_bib30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J.\u00a0R. Stat. Soc. B."},{"key":"10.1016\/j.ajhg.2020.10.001_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ajhg.2020.10.001_bib32","first-page":"1","article-title":"Dosing animal via diet: This can be a simple and efficient method for delivering compounds to lab animals when done correctly","volume":"5","author":"Ricci","year":"2012","journal-title":"ALN World."},{"key":"10.1016\/j.ajhg.2020.10.001_bib33","doi-asserted-by":"crossref","first-page":"e0168009","DOI":"10.1371\/journal.pone.0168009","article-title":"Perinatal Natural History of the Ts1Cje Mouse Model of Down Syndrome: Growth Restriction, Early Mortality, Heart Defects, and Delayed Development","volume":"11","author":"Ferr\u00e9s","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ajhg.2020.10.001_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-1-60327-099-1_10","article-title":"Developmental Milestones in the Newborn Mouse","volume":"39","author":"Hill","year":"2008","journal-title":"Neuromethods"},{"key":"10.1016\/j.ajhg.2020.10.001_bib35","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/ajmg.a.37156","article-title":"The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome","volume":"167A","author":"Guedj","year":"2015","journal-title":"Am. J. Med. Genet. A."},{"key":"10.1016\/j.ajhg.2020.10.001_bib114","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1016\/j.bmc.2011.03.042","article-title":"Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids","volume":"19","author":"Androutsopoulos","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ajhg.2020.10.001_bib115","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1080\/00365521.2018.1455893","article-title":"Lifetime alcohol intake and pattern of alcohol consumption in patients with alcohol-induced pancreatitis in comparison with patients with alcohol use disorder","volume":"53","author":"Juliusson","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib58","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.celrep.2017.05.031","article-title":"PLK1 Activation in Late G2 Sets Up Commitment to Mitosis","volume":"19","author":"Gheghiani","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ajhg.2020.10.001_bib116","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41419-018-0748-x","article-title":"SERPINB2 is a novel indicator of stem cell toxicity","volume":"9","author":"Lee","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ajhg.2020.10.001_bib117","first-page":"3537","article-title":"Apigenin accelerates lipopolysaccharide induced apoptosis in mesenchymal stem cells through suppressing vitamin D receptor expression","volume":"124","author":"Zhang","year":"2011","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.ajhg.2020.10.001_bib118","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.canlet.2014.08.039","article-title":"Overcoming cetuximab resistance in HNSCC: the role of AURKB and DUSP proteins","volume":"354","author":"Boeckx","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ajhg.2020.10.001_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.freeradbiomed.2017.07.009","article-title":"Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism","volume":"114","author":"Barone","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ajhg.2020.10.001_bib37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.33549\/physiolres.932722","article-title":"Oxidative stress and Down syndrome. Do antioxidants play a role in therapy?","volume":"63","author":"Muchov\u00e1","year":"2014","journal-title":"Physiol. Res."},{"key":"10.1016\/j.ajhg.2020.10.001_bib38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-4614-0653-2_22","article-title":"Oxidative stress and mitochondrial dysfunction in Down syndrome","volume":"724","author":"Pagano","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib39","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.bbadis.2011.12.010","article-title":"Antioxidants in Down syndrome","volume":"1822","author":"Lott","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ajhg.2020.10.001_bib40","first-page":"257","article-title":"Oxidative stress and neural dysfunction in Down syndrome","volume":"57","author":"Iannello","year":"1999","journal-title":"J.\u00a0Neural Transm. Suppl."},{"key":"10.1016\/j.ajhg.2020.10.001_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbadis.2013.10.014","article-title":"Decreased cell proliferation and higher oxidative stress in fibroblasts from Down Syndrome fetuses. Preliminary study","volume":"1842","author":"Gimeno","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ajhg.2020.10.001_bib42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/prca.201000121","article-title":"Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid","volume":"5","author":"Perluigi","year":"2011","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.ajhg.2020.10.001_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-3-7091-6721-2_6","article-title":"An altered antioxidant balance occurs in Down syndrome fetal organs: implications for the \u201cgene dosage effect\u201d hypothesis","volume":"67","author":"de Haan","year":"2003","journal-title":"J.\u00a0Neural Transm. Suppl."},{"key":"10.1016\/j.ajhg.2020.10.001_bib44","doi-asserted-by":"crossref","first-page":"e91588","DOI":"10.1371\/journal.pone.0091588","article-title":"Plant flavone apigenin binds to nucleic acid bases and reduces oxidative DNA damage in prostate epithelial cells","volume":"9","author":"Sharma","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ajhg.2020.10.001_bib45","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.bmcl.2004.02.003","article-title":"Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblostoma cells","volume":"14","author":"Kang","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ajhg.2020.10.001_bib46","first-page":"724","article-title":"Attenuation of oxidative stress of erythrocytes by the plant-derived flavonoids vitexin and apigenin","volume":"70","author":"An","year":"2015","journal-title":"Pharmazie"},{"key":"10.1016\/j.ajhg.2020.10.001_bib47","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.phrs.2017.10.008","article-title":"Apigenin as neuroprotective agent: Of mice and men","volume":"128","author":"Nabavi","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ajhg.2020.10.001_bib48","first-page":"2303","article-title":"Apigenin inhibits indoxyl sulfate-induced endoplasmic reticulum stress and anti-proliferative pathways, CHOP and IL-6\/p21, in human renal proximal tubular cells","volume":"19","author":"Jeon","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ajhg.2020.10.001_bib49","doi-asserted-by":"crossref","first-page":"e0130599","DOI":"10.1371\/journal.pone.0130599","article-title":"Luteolin and Apigenin Attenuate 4-Hydroxy-2-Nonenal-Mediated Cell Death through Modulation of UPR, Nrf2-ARE and MAPK Pathways in PC12 Cells","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ajhg.2020.10.001_bib50","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ptr.1900","article-title":"A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.)","volume":"20","author":"McKay","year":"2006","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ajhg.2020.10.001_bib51","first-page":"773","article-title":"Plasma nerve growth factor (NGF) and inflammatory cytokines (IL-6 and MCP-1) in young and adult subjects with Down syndrome: an interesting pathway","volume":"27","author":"Corsi","year":"2006","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.ajhg.2020.10.001_bib52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/205873920601900118","article-title":"Altered vessel signalling molecules in subjects with Downs syndrome","volume":"19","author":"Licastro","year":"2006","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib53","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jalz.2016.05.001","article-title":"An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation","volume":"12","author":"Iulita","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ajhg.2020.10.001_bib54","doi-asserted-by":"crossref","first-page":"e107072","DOI":"10.1371\/journal.pone.0107072","article-title":"Flavonoid apigenin inhibits lipopolysaccharide-induced inflammatory response through multiple mechanisms in macrophages","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ajhg.2020.10.001_bib55","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fphar.2018.00220","article-title":"Apigenin and Luteolin Attenuate the Breaching of MDA-MB231 Breast Cancer Spheroids Through the Lymph Endothelial Barrier in\u00a0Vitro","volume":"9","author":"Hong","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib56","doi-asserted-by":"crossref","first-page":"e0175558","DOI":"10.1371\/journal.pone.0175558","article-title":"Apigenin inhibits TNF\u03b1\/IL-1\u03b1-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells","volume":"12","author":"Bauer","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ajhg.2020.10.001_bib57","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.celrep.2018.06.087","article-title":"WAC Promotes Polo-like Kinase 1 Activation for Timely Mitotic Entry","volume":"24","author":"Qi","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ajhg.2020.10.001_bib59","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s004010000230","article-title":"The developmental and aging changes of Down\u2019s syndrome cell adhesion molecule expression in normal and Down\u2019s syndrome brains","volume":"100","author":"Saito","year":"2000","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000048808","article-title":"Down syndrome cell adhesion molecule is conserved in mouse and highly expressed in the adult mouse brain","volume":"94","author":"Barlow","year":"2001","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.ajhg.2020.10.001_bib61","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1073\/pnas.1109099109","article-title":"Trisomy of the G protein-coupled K+ channel gene, Kcnj6, affects reward mechanisms, cognitive functions, and synaptic plasticity in mice","volume":"109","author":"Cooper","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2020.10.001_bib62","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.1093\/hmg\/ddv364","article-title":"Genetic dissection of the Down syndrome critical region","volume":"24","author":"Jiang","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ajhg.2020.10.001_bib63","first-page":"923","article-title":"Brain ventriculomegaly in Down syndrome mice is caused by Pcp4 dose-dependent cilia dysfunction","volume":"26","author":"Raveau","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ajhg.2020.10.001_bib64","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.nbd.2013.11.016","article-title":"Developmental molecular and functional cerebellar alterations induced by PCP4\/PEP19 overexpression: implications for Down syndrome","volume":"63","author":"Mouton-Liger","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ajhg.2020.10.001_bib65","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1517\/13543770902721279","article-title":"Apigenin and related compounds stimulate adult neurogenesis. Mars, Inc., the Salk Institute for Biological Studies: WO2008147483","volume":"19","author":"Taupin","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ajhg.2020.10.001_bib66","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4103\/1673-5374.248519","article-title":"Luteolin induces hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome","volume":"14","author":"Zhou","year":"2019","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ajhg.2020.10.001_bib67","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cbi.2017.03.016","article-title":"Protective role of apigenin on rotenone induced rat model of Parkinson\u2019s disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis","volume":"269","author":"Anusha","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ajhg.2020.10.001_bib68","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0278-6915(03)00146-7","article-title":"Modulation of lipopolysaccharide-induced proinflammatory cytokine production in\u00a0vitro and in\u00a0vivo by the herbal constituents apigenin (chamomile), ginsenoside Rb(1) (ginseng) and parthenolide (feverfew)","volume":"41","author":"Smolinski","year":"2003","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib69","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neuropharm.2014.07.012","article-title":"Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice","volume":"86","author":"Patil","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ajhg.2020.10.001_bib70","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.archger.2017.07.004","article-title":"Apigenin attenuates isoflurane-induced cognitive dysfunction via epigenetic regulation and neuroinflammation in aged rats","volume":"73","author":"Chen","year":"2017","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.ajhg.2020.10.001_bib71","doi-asserted-by":"crossref","first-page":"e20196","DOI":"10.7554\/eLife.20196","article-title":"Signaling a link between interferon and the traits of Down syndrome","volume":"5","author":"Kirsammer","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.ajhg.2020.10.001_bib72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1126\/science.186.4158.61","article-title":"Human chromosome 21 dosage: effect on the expression of the interferon induced antiviral state","volume":"186","author":"Tan","year":"1974","journal-title":"Science"},{"key":"10.1016\/j.ajhg.2020.10.001_bib73","doi-asserted-by":"crossref","first-page":"84489","DOI":"10.18632\/oncotarget.21060","article-title":"Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajhg.2020.10.001_bib74","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1046\/j.1460-9568.2002.02287.x","article-title":"Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopolysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages","volume":"16","author":"H\u00e4usler","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ajhg.2020.10.001_bib75","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0165-5728(02)00050-4","article-title":"Up-regulation of the inflammatory cytokines IFN-gamma and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APP(SWE) transgenic mice","volume":"126","author":"Abbas","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib76","doi-asserted-by":"crossref","first-page":"11244","DOI":"10.1128\/JVI.01413-09","article-title":"Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels","volume":"83","author":"Tribouillard-Tanvier","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib77","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1084\/jem.178.3.1041","article-title":"Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor\/IL-12 synthesis in accessory cells","volume":"178","author":"D\u2019Andrea","year":"1993","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ajhg.2020.10.001_bib78","doi-asserted-by":"crossref","first-page":"153237","DOI":"10.1016\/j.phymed.2020.153237","article-title":"Anthocyanins isolated from Hibiscus syriacus L. attenuate lipopolysaccharide-induced inflammation and endotoxic shock by inhibiting the TLR4\/MD2-mediated NF-\u03baB signaling pathway","volume":"76","author":"Karunarathne","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ajhg.2020.10.001_bib79","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.intimp.2009.08.015","article-title":"Anti-inflammatory effects of apigenin on nicotine- and lipopolysaccharide-stimulated human periodontal ligament cells via heme oxygenase-1","volume":"9","author":"Jeong","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib80","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1744-313X.2010.00914.x","article-title":"Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome","volume":"37","author":"Cetiner","year":"2010","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.ajhg.2020.10.001_bib81","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1684\/ecn.2012.0307","article-title":"Altered serum pro-inflammatory cytokines in children with Down\u2019s syndrome","volume":"23","author":"Nateghi Rostami","year":"2012","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.ajhg.2020.10.001_bib82","doi-asserted-by":"crossref","first-page":"154938","DOI":"10.1016\/j.cyto.2019.154938","article-title":"Increased systemic inflammation in children with Down syndrome","volume":"127","author":"Huggard","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.ajhg.2020.10.001_bib83","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1902\/jop.2011.110056","article-title":"Expression of the interleukin-10 signaling pathway genes in individuals with Down syndrome and periodontitis","volume":"83","author":"Cavalcante","year":"2012","journal-title":"J.\u00a0Periodontol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib84","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cca.2014.03.002","article-title":"Alterations of ectonucleotidases and acetylcholinesterase activities in lymphocytes of Down syndrome subjects: relation with inflammatory parameters","volume":"433","author":"Rodrigues","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ajhg.2020.10.001_bib85","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s10753-015-0294-y","article-title":"Apigenin Attenuates Experimental Autoimmune Myocarditis by Modulating Th1\/Th2 Cytokine Balance in Mice","volume":"39","author":"Zhang","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.ajhg.2020.10.001_bib86","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/08923973.2016.1173058","article-title":"Anti-oxidant and anti-inflammatory effects of apigenin in a rat model of sepsis: an immunological, biochemical, and histopathological study","volume":"38","author":"Karamese","year":"2016","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib87","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fnagi.2020.00119","article-title":"Neuroimmunomodulatory and Neuroprotective Effects of the Flavonoid Apigenin in in\u00a0vitro Models of Neuroinflammation Associated With Alzheimer\u2019s Disease","volume":"12","author":"Dourado","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ajhg.2020.10.001_bib88","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1038\/npp.2009.68","article-title":"Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization","volume":"34","author":"Greene","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ajhg.2020.10.001_bib89","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.cell.2016.03.033","article-title":"Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity","volume":"165","author":"Jais","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ajhg.2020.10.001_bib90","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00005072-198605000-00003","article-title":"The growth and development of microvasculature in human cerebral cortex","volume":"45","author":"Norman","year":"1986","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib91","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00418-003-0510-y","article-title":"VEGF expression is developmentally regulated during human brain angiogenesis","volume":"119","author":"Virgintino","year":"2003","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib92","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/aja.1002040303","article-title":"Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development","volume":"204","author":"Breier","year":"1995","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.ajhg.2020.10.001_bib93","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/380439a0","article-title":"Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene","volume":"380","author":"Ferrara","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2020.10.001_bib94","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/380435a0","article-title":"Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele","volume":"380","author":"Carmeliet","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2020.10.001_bib95","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/376062a0","article-title":"Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice","volume":"376","author":"Shalaby","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2020.10.001_bib96","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1073\/pnas.1007640108","article-title":"Reversible modulations of neuronal plasticity by VEGF","volume":"108","author":"Licht","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2020.10.001_bib97","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jamaneurol.2014.4761","article-title":"The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease","volume":"72","author":"Hohman","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib98","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1038\/tp.2014.58","article-title":"Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals","volume":"4","author":"Paterson","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ajhg.2020.10.001_bib99","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2362.2010.02370.x","article-title":"VEGF and nitric oxide synthase immunoexpression in Down\u2019s syndrome amniotic fluid stem cells","volume":"41","author":"Salvolini","year":"2011","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ajhg.2020.10.001_bib100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/jmf.13.1.28.31","article-title":"Amniotic levels of vascular endothelial growth factor and nitric oxide at the second trimester in Down\u2019s syndrome","volume":"13","author":"Tranquilli","year":"2003","journal-title":"J.\u00a0Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.ajhg.2020.10.001_bib101","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/3-211-32318-X_80","article-title":"Reduction of neural and vascular damage by transplantation of VEGF-secreting neural stem cells after cerebral ischemia","volume":"95","author":"Zhu","year":"2005","journal-title":"Acta Neurochir. Suppl. (Wien)"},{"key":"10.1016\/j.ajhg.2020.10.001_bib102","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1227\/01.NEU.0000166682.50272.BC","article-title":"Transplantation of vascular endothelial growth factor-transfected neural stem cells into the rat brain provides neuroprotection after transient focal cerebral ischemia","volume":"57","author":"Zhu","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ajhg.2020.10.001_bib103","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/pr.2012.191","article-title":"VEGF expression and microvascular responses to severe transient hypoxia in the fetal sheep brain","volume":"73","author":"Baburamani","year":"2013","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ajhg.2020.10.001_bib104","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1089\/hum.2016.046","article-title":"Maternal Therapy with Ad.VEGF-A165 Increases Fetal Weight at Term in a Guinea-Pig Model of Fetal Growth Restriction","volume":"27","author":"Swanson","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ajhg.2020.10.001_bib105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/gene.2009.77","article-title":"Interleukin-7 (IL-7) and IL-7 splice variants affect differentiation of human neural progenitor cells","volume":"11","author":"Moors","year":"2010","journal-title":"Genes Immun."},{"key":"10.1016\/j.ajhg.2020.10.001_bib106","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0006-8993(93)90400-H","article-title":"Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors","volume":"600","author":"Araujo","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.ajhg.2020.10.001_bib107","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/dbio.1996.0255","article-title":"Interleukin-7 is trophic for embryonic neurons and is expressed in developing brain","volume":"179","author":"Michaelson","year":"1996","journal-title":"Dev. Biol."},{"key":"10.1016\/j.ajhg.2020.10.001_bib108","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/1028415X.2018.1478653","article-title":"Apigenin reverses behavioral impairments and cognitive decline in kindled mice via CREB-BDNF upregulation in the hippocampus","volume":"23","author":"Sharma","year":"2020","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.ajhg.2020.10.001_bib109","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2174\/18715273113129990084","article-title":"Effects of palmitoylethanolamide and luteolin in an animal model of anxiety\/depression","volume":"12","author":"Crupi","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.ajhg.2020.10.001_bib110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1142\/S0192415X10007841","article-title":"The ameliorating effects of luteolin on beta-amyloid-induced impairment of water maze performance and passive avoidance in rats","volume":"38","author":"Tsai","year":"2010","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.ajhg.2020.10.001_bib111","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.12659\/MSM.902770","article-title":"Apigenin Ameliorates Post-Stroke Cognitive Deficits in Rats Through Histone Acetylation-Mediated Neurochemical Alterations","volume":"23","author":"Tu","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ajhg.2020.10.001_bib112","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/dmd.104.000893","article-title":"Pharmacokinetics and metabolism of apigenin in female and male rats after a single oral administration","volume":"33","author":"Gradolatto","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ajhg.2020.10.001_bib113","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.2174\/092986710792927813","article-title":"Hormonal action of plant derived and anthropogenic non-steroidal estrogenic compounds: phytoestrogens and xenoestrogens","volume":"17","author":"L\u00f3r\u00e1nd","year":"2010","journal-title":"Curr. Med. Chem."}],"container-title":["The American Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929720303591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929720303591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:19:49Z","timestamp":1762078789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002929720303591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":118,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0002929720303591"],"URL":"https:\/\/doi.org\/10.1016\/j.ajhg.2020.10.001","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/495283","asserted-by":"object"}]},"ISSN":["0002-9297"],"issn-type":[{"value":"0002-9297","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Human Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajhg.2020.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020","name":"copyright","label":"Copyright"}]}}